How Microbes and Metabolism May Predict Skin Cancer Immunotherapy Outcomes
The purpose of this research study is to examine the relationship between the microbiota (microscopic organisms) in the gut and the activity of the immune system during skin cancer immunotherapy.
Autoimmunity|Melanoma|Merkel Cell Carcinoma|Squamous Cell Carcinoma of the Skin|Basal Cell Carcinoma|Skin Cancer
BIOLOGICAL: Immunotherapy
Immune-related Adverse Events (irAEs), Electronic medical records will be queried for specific drug-related adverse events known as immune-related Adverse Events (irAEs) including but not limited to colitis, hypophysitis, hepatitis, pneumonitis, pancreatitis, arthritis, rash, and vitiligo., 2 years
Overall Survival, Overall Survival, 2 years
Details will be available upon publication.